El reto del envejecimiento y la complejidad farmacoterapéutica en el paciente VIH+ [PDF]
, 2018 Objective: To describe the current knowledge and management of aging and pharmacotherapeutic complexity in HIV + patients. Method: A review of literature was carried out, including articles, originals or reviews, published in English or Spanish, from ...
Abdel Kader Martín, Laila +3 more
core +3 more sources
Clinical and Translational Science, 2023 Polypharmacy may cause adverse health outcomes in the elderly. This study examined the prevalence of continuous polypharmacy and hyper‐polypharmacy, factors associated with polypharmacy, and the most frequently prescribed medications among older adults ...
Ho Jin Cho +3 more
doaj +1 more source
Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. [PDF]
, 2015 PURPOSE: The use of multiple and/or inappropriate medications in seniors is a significant public health problem, and cancer treatment escalates its prevalence and complexity.
Andrel-Sendecki, Jocelyn +4 more
core +2 more sources
Coping with complexity: working beyond the guidelines for patients with multimorbidities [PDF]
, 2015 Primary care physicians believe they are delivering evidence-based care, understanding that adherence to evidence-based clinical guidelines results in tangible benefits in the populations for which they were developed.
Treadwell, Julian
core +6 more sources
BMJ Open, 2016 Objectives (1) To evaluate the prevalence of polypharmacy (5–9 medicines) and excessive polypharmacy (10+ medicines) and (2) to determine associated demographic and clinical characteristics in an ageing population with intellectual disabilities (IDs ...
Mary McCarron +4 more
doaj +1 more source
An overview of prevalence, determinants and health outcomes of polypharmacy
Therapeutic Advances in Drug Safety, 2020 A high rate of polypharmacy is, in part, a consequence of the increasing proportion of multimorbidity in the ageing population worldwide. Our understanding of the potential harm of taking multiple medications in an older, multi-morbid population, who are
Mina Khezrian +3 more
doaj +1 more source
Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study [PDF]
Intestinal Research, 2019 Background/Aims Polypharmacy is a common clinical problem with chronic diseases that can be associated with adverse patient outcomes. The present study aimed to determine the prevalence and patient-specific characteristics associated with polypharmacy in
Jingzhou Wang +3 more
doaj +1 more source
The potential for deprescribing in care home residents with Type 2 diabetes [PDF]
, 2016 Background: Type 2 diabetes is a common diagnosis in care home residents that is associated with potentially inappropriate prescribing and thus risk of additional suffering.
Andreassen, Lillan Mo +4 more
core +1 more source
Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020 Background Polypharmacy is highly prevalent in elderly people with chronic conditions, including atrial fibrillation (AF). The impact of polypharmacy on adverse outcomes and on treatment effectiveness in elderly patients with AF remains unaddressed ...
Nemin Chen +7 more
doaj +1 more source
Frontiers in Pharmacology, 2021 Introduction: Polypharmacy is a risk factor for adverse health outcomes, higher use of medical services and additional costs. The problem has gained attention as a consequence of aging and related multimorbidity.
Przemysław Kardas +5 more
doaj +1 more source